Debra York
Psychiatric/Mental Health · Nashville, TNNPI 1154635118
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Idorsia Pharmaceuticals US Inc accounts for 70.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $6,649 and has fallen 95.3% since, to $314 in 2025. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $65.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Idorsia Pharmaceuticals US Inc$6K
- Alkermes, Inc.$680
- Otsuka America Pharmaceutical, Inc.$358
- Sunovion Pharmaceuticals Inc.$294
- Axsome Therapeutics, Inc.$262
- AbbVie$234
- plus $895 from 10 others
What the payments were for
- Speaking & faculty fees$4,90053%
- Travel & lodging$1,23213%
- Food & beverage$3,03233%
- Education$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Idorsia Pharmaceuticals US Inc | 22 | $6,480 |
| Alkermes, Inc. | 35 | $680 |
| Otsuka America Pharmaceutical, Inc. | 18 | $358 |
| Sunovion Pharmaceuticals Inc. | 13 | $294 |
| Axsome Therapeutics, Inc. | 11 | $262 |
| AbbVie(2 entities) | 8 | $234 |
| Eisai Inc. | 7 | $173 |
| Johnson & Johnson | 4 | $170 |
| Vanda Pharmaceuticals Inc. | 6 | $139 |
| Novo Nordisk | 1 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Lundbeck LLC | 4 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| Adlon Therapeutics L.p. | 2 | $37 |
| Merck | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,203 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 16 | $22,226 |
| DayvigoLemborexant | 21 | $6,885 |
| QuviviqDaridorexant Hcl | 11 | $4,906 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $1,394 |
| Aripiprazole | 14 | $200 |
| Gabapentin | 11 | $161 |
| Trazodone Hcl | 16 | $142 |
| Clonazepam | 30 | $111 |
| Lorazepam | 12 | $98 |
| Buspirone Hcl | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $234 | $22,22616 claims |
| Eisai Inc.Dayvigo | $173 | $6,88521 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $6,480 | $4,90611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Nashville
- Kristian DambrinoNashville$449K
- Lauren HansenNashville$263K
- Aaron JonesNashville$20K
- Kathleen McCoyNashville$12K
- Preeti SrivastavaNashville$11K
- Kersten WoodleeNashville$10K
- Ariel NewtonNashville$10K
- Robert McKeownNashville$10K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.